Shasqi

company

About

Pioneering in-human click chemistry against cancer

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$179.99K
Industries
Biotechnology,Emergency Medicine,Health Care,Medical
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Shasqi is leading the development of therapeutics leveraging click chemistry to get active cancer treatments to tumors with its proprietary CAPAC™ (Click Activated Protodrugs Against Cancer) platform. The technology is based on localizing a click chemistry reagent in the tumor area, which then activates a second agent, a systemically infused protodrug. When the two ‘click’, a powerful localized therapy is activated at the tumor, while keeping its systemic exposure levels below toxic thresholds. We have already proven that our platform works in humans, which opens up an array of future possibilities for click-chemistry based therapies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.42M
Shasqi has raised a total of $1.42M in funding over 2 rounds. Their latest funding was raised on Apr 4, 2017 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 4, 2017 Grant $1.24M 1 National Science Foundation Detail
Dec 8, 2015 Grant $179.99K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Shasqi is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant